fashion -WSS

fashion

author：entertainment 2025-09-27 12:57:31 - browse：88654

Silhouetted hands passing money. -- health business coverage from STAT — Adobe

The federal government has started penalizing Medicare Advantage insurers that have one common, glaring problem: Faulty technology systems are leading to people paying more for care and coverage than they should be.

The Centers for Medicare and Medicaid Services fined three different Medicare Advantage plans this month, each one getting dinged differently for the way they overcharged their members. The fines are minuscule for the insurance companies — roughly equivalent to some pennies under a couch cushion — but they could serve as warnings for companies to clean up their compliance and IT infrastructure before regulators knock on their doors again.

“Just the knowledge that CMS will be back one day and that you better have this fixed, I think, does have a sentinel effect,” said Philip Legendy, an attorney at Ballard Spahr who represents Medicare Advantage plans. “And if you’re doing it over and over, it could be viewed as intentional.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： David Sabatini, ex

knowledge

WSS

In his State of the Union, Biden takes clear aim at 'Big Pharma'

Childbirth

Readout Newsletter: Amylyx, Alto Neuro, and Eli Lilly for the Oscars

Readout Newsletter: Acadia, Eli Lilly, Madrigal Pharma updates

Antibiotic resistance nearly killed me, so I'm raising awareness of it

Precocious puberty in girls comes with mental health risks

Wikipedia

fashion

focus

The high cost of giving birth even with insurance

Scientists successfully use ultrasound imaging to map brain activity

In age of alternative facts, a scholarly course on calling out crap

Sen. Paul opposes bill to ban Chinese biotechs

In age of alternative facts, a scholarly course on calling out crap

In his State of the Union, Biden takes clear aim at 'Big Pharma'

Medicare proposal to cover medical devices draws a mixed reaction

Insmed lung disease drug hits target in key Phase 3 trial

Apple is now the first public company to be valued at $3 trillion

The problem with charging patients to message their doctors

explore

Readout LOUD podcast: Venture capital turmoil, obesity drug competition

In his State of the Union, Biden takes clear aim at 'Big Pharma'

Precocious puberty in girls comes with mental health risks

Dark money group runs ads on China biotech bill

Lab trade group sues FDA to halt regulation of lab

Report: NIH

hotspot

knowledge

focus

focus